Crohn's Disease Presenting With Secondary Immunoglobulin A Nephropathy and Cutaneous Vasculitis: Unusual Extraintestinal Manifestations. [PDF]
Kar S +7 more
europepmc +1 more source
Predicting the Course of Immunoglobulin A Nephropathy Using Urinary Soluble Cluster of Differentiation 163 as a Prognostic Biomarker. [PDF]
Hossain SKA +10 more
europepmc +1 more source
Accuracy of ICD-10 coding for identifying immunoglobulin A nephropathy (IgAN) prior to 2023. [PDF]
Sumantri AP +4 more
europepmc +1 more source
Treatment of immunoglobulin A nephropathy: Current perspective and future prospects. [PDF]
Şener YZ, Şener S.
europepmc +1 more source
Efficacy and safety of telitacicept in the treatment of immunoglobulin a nephropathy: a real-world, single-center, retrospective study. [PDF]
Luo L +9 more
europepmc +1 more source
Impact of Particulate Matter on the Exacerbation of Immunoglobulin A Nephropathy: An Animal Experimental Study. [PDF]
Lee M +11 more
europepmc +1 more source
The Impact of Gut Microbiota on Immunoglobulin A Nephropathy through the Mediation of Specific Immune Cells: A Mendelian Randomization Study. [PDF]
Wan J, Yang M, Chen Q, Li S, Ye X, Li Q.
europepmc +1 more source
The incidence and prevalence of immunoglobulin A nephropathy in the United States. [PDF]
DeCongelio M +4 more
europepmc +1 more source
Treatment patterns, clinical outcomes, and economic burden among patients with immunoglobulin A nephropathy (IgAN) in China. [PDF]
Liu Y +12 more
europepmc +1 more source
Matching-adjusted indirect comparison of kidney function in patients with immunoglobulin A nephropathy treated with nefecon or sparsentan. [PDF]
Ngai C +4 more
europepmc +1 more source

